en
Scientific article
Open access
English

Regulation of the endothelial plasminogen activator system by fluvastatin. Role of Rho family proteins, actin polymerisation and p38 MAP kinase

Published inThrombosis and haemostasis, vol. 105, no. 3, p. 461-472
Publication date2011
Abstract

Statins are cholesterol-lowering drugs that exert pleiotropic effects which include changes in the plasminogen activation (PA) system of endothelial cells (EC). It was the objective of this study to investigate the signal transduction pathways by which statins increase the expression of tissue-type PA (t-PA) and decrease PA inhibitor type 1 (PAI-1) in human umbilical vein EC. Fluvastatin treatment increased t-PA expression more than 10-fold and reduced PAI-1 expression up to five-fold. This effect was mimicked by geranylgeranyl transferase inhibition. The role of geranylgeranylated small G-proteins of the Rho family was assessed by adenovirus-mediated expression of dominant negative (DN) RhoA, Cdc42 and Rac1 and by siRNA-mediated suppression of these proteins. DN-Cdc42 and DN-Rac1, as well as siRNA for Cdc42, increased t-PA expression, while DN-RhoA and DN-Rac1 decreased PAI-1 expression. Latrunculin B, an inhibitor of actin polymerisation, increased t-PA mRNA and reduced PAI-1 mRNA to the same extent as fluvastatin. Inhibition of p38, as well as p38α or p38β siRNA, reversed the effects of fluvastatin on t-PA expression. Treatment with p38β siRNA partially reversed the effect of fluvastatin on PAI-1, whereas p38α siRNA had no significant effect. Inhibition of jun kinase reduced basal and fluvastatin-induced t-PA expression to the same extent and increased PAI-1. MEK/ERK inhibition had no effect. In human EC, the fluvastatin-induced increase in t-PA is mediated by Cdc42 and, as with t-PA induced by inhibition of actin polymerisation, requires activation of p38MAP kinase. The mechanisms by which fluvastatin treatment reduces PAI-1 are different from those that increase t-PA.

Keywords
  • Actins/chemistry
  • Adenoviridae/genetics
  • Alkyl and Aryl Transferases/antagonists & inhibitors
  • Bicyclo Compounds, Heterocyclic/metabolism
  • Dose-Response Relationship, Drug
  • Endothelial Cells/cytology
  • Fatty Acids, Monounsaturated/metabolism/pharmacology
  • GTP-Binding Proteins/metabolism
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology
  • Indoles/metabolism/pharmacology
  • Plasminogen Activators/metabolism
  • RNA, Small Interfering/metabolism
  • Reverse Transcriptase Polymerase Chain Reaction
  • Thiazolidines/metabolism
  • Cdc42 GTP-Binding Protein/metabolism
  • P38 Mitogen-Activated Protein Kinases/metabolism
Citation (ISO format)
GEINDRE, Sylvie Françoise, FISH, Richard, KRUITHOF, Egbert. Regulation of the endothelial plasminogen activator system by fluvastatin. Role of Rho family proteins, actin polymerisation and p38 MAP kinase. In: Thrombosis and haemostasis, 2011, vol. 105, n° 3, p. 461–472. doi: 10.1160/TH10-07-0444
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
ISSN of the journal0340-6245
553views
273downloads

Technical informations

Creation2014/04/11 13:55:00
First validation2014/04/11 13:55:00
Update time2023/03/14 21:10:29
Status update2023/03/14 21:10:29
Last indexation2024/01/16 09:52:02
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack